Clinical Trial – Exercise Intervention Among Androgen Deprivation Therapy – Prostate Cancer

This research study is evaluating the impact and feasibility of a 12-week brisk walking and moderate strength training exercise intervention including a virtual component in men who are initiating androgen deprivation therapy (ADT) for prostate cancer.

Study Type  : Interventional  (Clinical Trial)
Estimated Enrollment  : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy: A Pilot Study
Actual Study Start Date  : December 8, 2017
Estimated Primary Completion Date  : February 25, 2020
Estimated Study Completion Date  : February 25, 2022

Contacts
Contact: Ninjin Boldbaatar, MPH 617-525-3185 nboldbaatar@bwh.harvard.edu
Contact: Paul L. Nguyen, MD 617-732-7936 PNGUYEN@lroc.harvard.edu

ClinicalTrials.gov Identifier: NCT03070145

Locations
United States, Massachusetts
Dana Farber Cancer Institute Recruiting
Boston, Massachusetts, United States, 02215
Contact: Paul Nguyen, MD 617-732-7936 PNGUYEN@lroc.harvard.edu
Principal Investigator: Paul Nguyen, MD

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.